These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 27979961

  • 21. Evaluation of a novel multiplex RT-qPCR assay for the quantification of leukemia-associated BCR-ABL1 translocation.
    Kottwitz D, El Hadi H, El Amrani M, Cabezas S, Dehbi H, Nadifi S, Quessar A, Colomer D, Moumen A, Sefrioui EL.
    Int J Hematol; 2015 Sep; 102(3):335-41. PubMed ID: 26243622
    [Abstract] [Full Text] [Related]

  • 22. A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukemia patients.
    Testoni N, Martinelli G, Farabegoli P, Zaccaria A, Amabile M, Raspadori D, Pelliconi S, Zuffa E, Carboni C, Tura S.
    Blood; 1996 May 01; 87(9):3822-7. PubMed ID: 8611708
    [Abstract] [Full Text] [Related]

  • 23. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P, Müller MC, Merx K, Kreil S, Schoch C, Lahaye T, Weisser A, Petzold A, König H, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2003 Sep 01; 17(9):1687-94. PubMed ID: 12970765
    [Abstract] [Full Text] [Related]

  • 24. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
    Merx K, Müller MC, Kreil S, Lahaye T, Paschka P, Schoch C, Weisser A, Kuhn C, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2002 Sep 01; 16(9):1579-83. PubMed ID: 12200666
    [Abstract] [Full Text] [Related]

  • 25. Advantages of digital PCR in the detection of low abundance BCR-ABL1 gene in patients with chronic myeloid leukemia.
    Yan Z, Sun Q, Zhang H, Han Y, Qiao J, Niu M, Zhu S, Zhao K, Wu Q, Cheng H, Cao J, Zeng L, Li Z, Xu K.
    Oncol Lett; 2019 Nov 01; 18(5):5139-5144. PubMed ID: 31612025
    [Abstract] [Full Text] [Related]

  • 26. Comparison of molecular responses based on BCR-ABL1% (IS) results from an in-house TaqMan-based qPCR versus Xpert(®) assay in CML patients on tyrosine kinase inhibitor therapy.
    Boeckx N, Laer CV, Roover JD, Wilmsen B, Bruyninckx K, Pauwels S.
    Acta Clin Belg; 2015 Aug 01; 70(4):237-43. PubMed ID: 26166681
    [Abstract] [Full Text] [Related]

  • 27. Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network.
    Schäfer V, White HE, Gerrard G, Möbius S, Saussele S, Franke GN, Mahon FX, Talmaci R, Colomer D, Soverini S, Machova Polakova K, Cross NCP, Hochhaus A, Ernst T.
    J Cancer Res Clin Oncol; 2021 Oct 01; 147(10):3081-3089. PubMed ID: 33677711
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of Xpert® BCR-ABL Ultra for the confirmation of BCR-ABL1 international scale conversion factors for the molecular monitoring of chronic myeloid leukaemia.
    Dominy KM, Simon IM, Sorouri-Khorashad J.
    Int J Lab Hematol; 2021 Feb 01; 43(1):e31-e34. PubMed ID: 32990400
    [No Abstract] [Full Text] [Related]

  • 29. Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.
    Brown JT, Beldorth IJ, Laosinchai-Wolf W, Fahey ME, Jefferson KL, Ruskin AK, Roth JJ, Cai L, Watt CD, Press RD, Yang F, Hedges JB, Andruss BF.
    J Mol Diagn; 2019 Jul 01; 21(4):718-733. PubMed ID: 31026597
    [Abstract] [Full Text] [Related]

  • 30. Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay.
    Goh HG, Lin M, Fukushima T, Saglio G, Kim D, Choi SY, Kim SH, Lee J, Lee YS, Oh SM, Kim DW.
    Leuk Lymphoma; 2011 May 01; 52(5):896-904. PubMed ID: 21338281
    [Abstract] [Full Text] [Related]

  • 31. Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.
    White HE, Hedges J, Bendit I, Branford S, Colomer D, Hochhaus A, Hughes T, Kamel-Reid S, Kim DW, Modur V, Müller MC, Pagnano KB, Pane F, Radich J, Cross NC, Labourier E.
    Clin Chem; 2013 Jun 01; 59(6):938-48. PubMed ID: 23471097
    [Abstract] [Full Text] [Related]

  • 32. Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale.
    Furuya D, Moriai M, Koizumi Y, Endo T, Asanuma K, Yanagihara N, Takahashi S.
    Int J Clin Oncol; 2019 Jul 01; 24(7):871-875. PubMed ID: 30798394
    [Abstract] [Full Text] [Related]

  • 33. Molecular Monitoring of Chronic Myeloid Leukemia.
    Dominy K, Mokretar K, Reid AG, Khorashad JS.
    Methods Mol Biol; 2020 Jul 01; 2065():153-173. PubMed ID: 31578694
    [Abstract] [Full Text] [Related]

  • 34. Molecular monitoring and mutations in chronic myeloid leukemia: how to get the most out of your tyrosine kinase inhibitor.
    Baccarani M, Soverini S, De Benedittis C.
    Am Soc Clin Oncol Educ Book; 2014 Jul 01; ():167-75. PubMed ID: 24857074
    [Abstract] [Full Text] [Related]

  • 35. Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients.
    Koren-Michowitz M, Shimoni A, Daraio F, Crasto F, Lorenzatti R, Volchek Y, Amariglio N, Gottardi E, Saglio G, Nagler A.
    Biol Blood Marrow Transplant; 2015 Oct 01; 21(10):1852-5. PubMed ID: 26151304
    [Abstract] [Full Text] [Related]

  • 36. Real-time quantitative reverse transcriptase polymerase chain reaction.
    Fan H, Robetorye RS.
    Methods Mol Biol; 2010 Oct 01; 630():199-213. PubMed ID: 20300999
    [Abstract] [Full Text] [Related]

  • 37. Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response.
    Iacobucci I, Lonetti A, Venturi C, Ferrari A, Papayannidis C, Ottaviani E, Abbenante MC, Paolini S, Bresciani P, Potenza L, Parisi S, Cattina F, Soverini S, Russo D, Luppi M, Martinelli G.
    Leuk Res; 2014 May 01; 38(5):581-5. PubMed ID: 24630366
    [Abstract] [Full Text] [Related]

  • 38. Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia Patients.
    Cortés AA, Olmedillas S, Serrano-López J, Lainez-González D, Castaño T, Iñiguez R, Lopez-Lorenzo JL, García A, Atance M, Sánchez RNS, Lopez CB, Arranz MG, Sillero PL, Alonso-Dominguez JM.
    Mol Diagn Ther; 2020 Oct 01; 24(5):593-600. PubMed ID: 32875515
    [Abstract] [Full Text] [Related]

  • 39. [Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].
    Xing W, Gu BW, Zhu YM, Jiang CL, Zhao RH, Wang AH, Sun HP, Li JM, Shen ZX, Chen Z, Chen SJ.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 23; 85(7):453-7. PubMed ID: 15854550
    [Abstract] [Full Text] [Related]

  • 40. Detection of BCR-ABL1 fusion gene transcripts in the saliva of Nigerian patients with chronic myeloid leukemia.
    Uzoma IC, Taiwo IA, Nna EO, Durosinmi MA, Ukaejiofo EO.
    Niger J Clin Pract; 2019 Jan 23; 22(1):51-55. PubMed ID: 30666020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.